CORC

在结果中检索

CORC

浏览/检索结果: 共48条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Efficacy and safety of Run Zao Zhi Yang capsule on chronic eczema: a multiple-center, randomized, double-blind, placebo-controlled clinical study 期刊论文
2019, 卷号: 30, 期号: 7, 页码: 677-684
作者:  Huang, Dan;  Chen, Kun;  Zhang, Fu-Ren;  Yang, Sen;  Guo, Qing
收藏  |  浏览/下载：16/0  |  提交时间：2020/01/03
Efficacy and safety of 0.05% cyclosporine ophthalmic emulsion in treatment of Chinese patients with moderate to severe dry eye disease: A 12-week, multicenter, randomized, double-masked, placebo-controlled phase III clinical study 期刊论文
2019, 卷号: 98, 期号: 31, 页码: e16710
作者:  Chen Di;  Zhang Shunhua;  Bian Ailing;  Hong Jing;  Deng Yingping
收藏  |  浏览/下载：16/0  |  提交时间：2020/01/03
IMpassion131: A phase III study comparing 1L atezolizumab with paclitaxel vs placebo with paclitaxel in treatment-naive patients with inoperable locally advanced or metastatic triple negative breast cancer (TNBC) 会议论文
CANCER RESEARCH, 2018-02-01
作者:  Miles, David;  Andre, Fabrice;  Gligorov, Joseph;  Verma, Sunil;  Xu, Binghe
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
A PHASE III, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF NEUCARDIN (TM) IN PATIENTS WITH CHRONIC HEART FAILURE 期刊论文
2018, 卷号: 71, 期号: 11, 页码: 668-668
作者:  Gao, Runlin;  Zhang, Jian;  Liu, Heping;  Wang, Lina;  Pang, Xiaohua
收藏  |  浏览/下载：13/0  |  提交时间：2020/01/03
IMpassion131: A phase III study comparing 1L atezolizumab with paclitaxel vs placebo with paclitaxel in treatment-naive patients with inoperable locally advanced or metastatic triple negative breast cancer (TNBC) 期刊论文
2018, 卷号: 78, 期号: 4
作者:  Miles, David;  Andre, Fabrice;  Gligorov, Joseph;  Verma, Sunil;  Xu, Binghe
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
A PHASE III, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF NEUCARDIN (TM) IN PATIENTS WITH CHRONIC HEART FAILURE 会议论文
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018-03-10
作者:  Gao, Runlin;  Zhang, Jian;  Liu, Heping;  Wang, Lina;  Pang, Xiaohua
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea 期刊论文
2018, 卷号: 77, 期号: 3, 页码: 355-363
作者:  Zhang, Fengchun;  Bae, Sang-Cheol;  Bass, Damon;  Chu, Myron;  Egginton, Sally
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/03
Dienogest for Treatment of Endometriosis in Chinese Women: A Placebo-Controlled, Randomized, Double-Blind Phase 3 Study 期刊论文
2018, 卷号: 27, 期号: 2, 页码: 148-155
作者:  Lang Jinghe;  Yu Qi;  Zhang Shulan;  Li Huajun;  Gude Kerstin
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/03
Efficacy and safety of third-line treatment with anlotinib in patients with refractory advanced non-small-cell lung cancer (ALTER-0303): a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
2017, 卷号: 18, 页码: S3-S3
作者:  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhao, Yizhuo;  Zhang, Li
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/03
IMpassion131: Phase III study comparing 1L atezolizumab with paclitaxel vs placebo with paclitaxel in treatment-naive patients with inoperable locally advanced or metastatic triple negative breast cancer (mTNBC) 会议论文
ANNALS OF ONCOLOGY, 2017-09-01
作者:  Miles, D.;  Andre, F.;  Gligorov, J.;  Verma, S.;  Xu, B.
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace